Short Summary
Astrazeneca filed a suit seeking permanent injunction and damages for infringing Indian Patent IN 297581 related to cancer treatment. The dispute centered on whether a Public Notice issued by the Department of Pharmaceuticals constituted Government Authorization allowing generic manufacturing. The Court clarified that the notice was merely for collating local manufacturer details, not an authorization to infringe.
Detailed Summary
of the Paris Local Division of the Unified Patent Court concerning a request for extension of time filed by the Bosch defendants. The judge-rapporteur rejected Bosch's request, finding that a non-redacted version of Valeo's 15 June 2026 filing had been deposited in the CMS simultaneously with the redacted version, and that Bosch had failed to exercise due diligence in accessing it. The court ruled that the deadlines under R.29(d) RdP run from 15 June 2026.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before Delhi High Court - Orders. Understanding the court's reasoning in Astrazeneca Ab vs MSN Laboratories Limited is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Gibraltar (Uk) LimitedvsThe Registrar Of Trade Marks
Gibraltar (Uk) Limited appealed the rejection of its trademark application for 'PROMAX' under Class 31, arguing that it was a prior user and should be accepted despite objections based on similarity to existing marks. The Madras High Court upheld the Registrar's decision, finding that the appellant’s mark was deceptively similar to cited marks already registered in the same class. The court emphasized that registering the single word 'PROMAX' would create an undue monopoly over a common formative mark.
Sankalp Rehabilitation TrustvsM/s.Merck Sharpe & Dohme Corp.
Sankalp Rehabilitation Trust filed two Original Petitions seeking the revocation and removal of Patents No. 207233 and 234103, both held by M/s. Merck Sharpe & Dohme Corp., in the Madras High Court. The petitioner sought to transfer these matters for adjudication regarding patent invalidity. However, the court noted that both patents had already expired on March 24, 2019. Consequently, the petitions were dismissed as infructuous.
Hami BrothersvsHami & Co. And Anr.
In this Bombay High Court case, Hami Brothers challenged the registration of the 'Majmua 96' trade mark held by Hami & Co., arguing that the numeral '96' was descriptive and thus invalid. The court examined whether the mark retained distinctiveness despite its age and use across various products. Ultimately, the court dismissed the petition, finding that there was insufficient evidence to prove the mark had lost its distinctive character or that it was registered fraudulently.
Drs Educational Society & Ors.vsRegistrar Of Trade Marks & Anr.
The Delhi High Court dismissed a writ petition filed by Drs Educational Society challenging the registration of the 'DRS' trademark. The petitioners argued that the registration was erroneous because the applicant had previously withdrawn their application, but the Registrar failed to act on this withdrawal. However, the court held that administrative lapses do not invalidate an accrued statutory right. It emphasized that disputes over trademark validity must be pursued through specific remedies under the Trademarks Act, 1999, rather than via a writ petition.
Tirupati Structurals LimitedvsJai Prakash Singhal
The Delhi High Court granted an interim injunction in favor of Tirupati Structurals Limited against Jai Prakash Singhal, finding that the defendant's use of 'MM TIRUPATI' was deceptively similar to the plaintiff's established mark 'TSL-TIRUPATI'. The court held that despite minor differences in prefixes, the identical and prominent shared element 'TIRUPATI', coupled with the similarity in goods (pipes and fittings), created a high likelihood of consumer confusion. This ruling reinforces the protection afforded by common law passing off principles against calculated attempts to capitalize on established goodwill.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.